logo
Plus   Neg
Share
Email
Comment

Jazz Pharma To Sell Women's Health Unit To Meda - Quick Facts

Jazz Pharmaceuticals plc (JAZZ) entered into a definitive agreement to sell its women's health business, comprising six products, to Meda, an international specialty pharmaceutical company, for $95 million cash. The sale includes products like Elestrin, Gastrocrom, Natelle One, AVC Cream, Gesticare DHA and Urelle. Net sales for these products in 2011 totaled $30.4 million.

According to the transaction, Meda would offer positions to nearly 60 Jazz Pharmaceuticals employees who directly support these products. Jazz Pharmaceuticals expects to recognize a non-recurring gain on the sale in the fourth quarter of 2012. The company intends to provide more detail about the financial impact of the transaction after closing. The transaction may close in the fourth quarter of 2012.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Google plans to commission three underwater cables in 2019 as part of efforts to expand its cloud business amid stiff competition from rivals Microsoft and Amazon. The three fiber-optic subsea cables will run across different routes. Google noted that it has spent $30 billion to improve its infrastructure over three years. McDonald's Corp. said Tuesday that all of its packaging worldwide will come from renewable, recycled or certified sources by 2025, up from the current figure of 50 percent. The fast food giant also aims to recycle guest packaging in all its restaurants by then, compared with only 10 percent of its restaurants currently. General Electric Co. (GE) will take an after-tax charge of $6.2 billion in its fourth quarter results as part of comprehensive review of its finance arm's insurance portfolio. The after-tax charge will be $7.5 billion when adjusted to the rate following the recent U.S. tax overhaul.
comments powered by Disqus
Follow RTT